New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
11:07 EDTTEF, SKUL, STI, NVAX, PHigh option volume stocks: TEF SKUL STI NVAX P
News For TEF;SKUL;STI;NVAX;P From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 17, 2014
10:31 EDTPPandora calls active on renewed speculation of an activist investor
Subscribe for More Information
10:20 EDTPPandora spikes higher, levels to watch
Shares are up 3% to $22.70 on a sharp spike in the last ten minutes. At current price resistance is at $23.23. Support is at $22.45, the opening price of the day.
10:16 EDTPRumor: Pandora moves up on renewed speculation of an activist investor
Subscribe for More Information
08:28 EDTNVAXNovavax management to meet with JPMorgan
Subscribe for More Information
07:26 EDTTEFTelefonica axes 1.6K German jobs after E-Plus deal, WSJ says
As Telefonica gains E-Plus, the company's German division will reduce over 1.6K staff members in the country, according to The Wall Street Journal, citing a person familiar with the matter. Telefonica's German division employs 9.1K workers total at the moment. Reference Link
06:39 EDTSTISunTrust intends to repurchase $230M of stock in next two quarters
Subscribe for More Information
06:06 EDTSTISunTrust reports Q3 EPS ex-items 81c, consensus 81c
Subscribe for More Information
October 16, 2014
15:26 EDTSTINotable companies reporting before tomorrow's open
Subscribe for More Information
11:15 EDTNVAXHigh option volume stocks
Subscribe for More Information
October 15, 2014
10:50 EDTPPandora November volatility elevated into Q3 and outlook
Subscribe for More Information
09:04 EDTSTISunTrust shares undervalued, says Sterne Agee
Subscribe for More Information
08:40 EDTNVAXNovavax RSV F Vaccine study evoked polyclonal antibody response
Novavax announced that its RSV F-protein nanoparticle vaccine candidate, or RSV F Vaccine, evoked a polyclonal antibody response to antigenic site II, the same site targeted by the monoclonal antibody palivizumab, resulting in protection from an RSV challenge in an animal model. Researchers at Novavax reported these findings in an online paper published by Vaccine titled: "An insect cell derived respiratory syncytial virus F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization." Greg Glenn, SVP, Research and Development at Novavax stated, "This study further characterizes the immune response to our RSV F Vaccine, including the production of both polyclonal palivizumab competing antibodies that target antigenic site II, as well as other neutralizing antigenic sites on the F-protein. In addition, our ability to assess the safety of our RSV F Vaccine relative to Lot 100 formalin inactivated vaccine, which is known to cause disease enhancement, and to demonstrate that our vaccine's efficacy is equivalent or better than palivizumab, gives us greater confidence that our RSV vaccine candidate will be both safe and effective."
October 14, 2014
08:40 EDTNVAXNovavax initiates Phase 2 clinical trial of RSV F vaccine
Novavax announced that enrollment has begun in a Phase 2 clinical trial of its respiratory syncytial virus, or RSV, F-protein nanoparticle vaccine candidate, in healthy elderly subjects. The trial is a randomized, observer-blinded, placebo-controlled Phase 2 study scheduled to enroll 1,600 elderly subjects at ten sites in the United States. The trial will evaluate the incidence of all respiratory illnesses due to RSV, including medically-attended respiratory illnesses due to RSV, and hospitalizations for respiratory illness due to RSV in community-living elderly adults who have been treated with placebo. The study will also evaluate the safety and immunogenicity of a 135g dose of the RSV F Vaccine compared with placebo. The trial will also estimate the efficacy of the RSV F Vaccine in reducing the incidence of respiratory illnesses due to RSV.
October 13, 2014
16:04 EDTSKULSkullcandy announces two ASTRO headsets compatible with Xbox One
Subscribe for More Information
10:26 EDTSKULSkullcandy management to meet with Roth Capital
Subscribe for More Information
07:22 EDTPSony/ATV could ditch licensing firms due to streaming dollars, NY Post reports
Sony/ATV Music Publishing (SNE) is considering no longer dealing with performance rights groups BMI and ASCP, and instead negotiating directly with online music services like Pandora (P), YouTube (GOOG) and Spotify due to outdated rules and low royalties, the New York Post reports. Reference Link
October 9, 2014
14:10 EDTPShazam, Sun Broadcasting to launch customized, interactive radio content
Subscribe for More Information
08:02 EDTPPandora announces new auto partnership with Ford Australia
Pandora (P) Internet Radio has officially announced its partnership with Ford (F) Australia. The launch, effective across a range of nameplates including Fiesta ST and Focus ST and Ford Kuga line up, will continue to roll out across other Ford nameplates including the Fiesta, Focus, Ranger and Transit range by early 2015. Pandora locally also partners with Holden and Mazda, and will soon be released on new model Nissans (NSANY).
07:29 EDTPPandora 2016 EBITDA likely to beat consensus, says Oppenheimer
Subscribe for More Information
October 8, 2014
06:28 EDTSTIM&T Bank, SunTrust may miss Q3 expectations, says Citigroup
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use